Vilari?o-G?ell CWider CAasly J.OWhite L.RRajput ARajput A.HLynch TKrygowska-Wajs AJasinska-Myga BOpala GBarcikowska MCzyzewski KRUEY-MEEI WUUitti R.JWszolek Z.KFarrer M.JRoss O.A.2020-02-252020-02-2520100364-5134https://scholars.lib.ntu.edu.tw/handle/123456789/463700[SDGs]SDG3pyridoxal kinase; attributable risk; case control study; controlled study; disease association; disease predisposition; gene frequency; genetic predisposition; genome; genotype; human; letter; major clinical study; neurologic disease; Parkinson disease; population risk; priority journal; substantia nigra; Asia; Cohort Studies; Continental Population Groups; DNA Mutational Analysis; Europe; False Positive Reactions; Gene Expression Profiling; Gene Frequency; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Genome-Wide Association Study; Genotype; Humans; North America; Parkinson Disease; Pyridoxal Kinase; Reproducibility of Results; Risk Factorsletter10.1002/ana.21962203733542-s2.0-77950546713